We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Ultrasound Can Be Used as a Painless and Viable Alternative to Losing Weight

By HospiMedica International staff writers
Posted on 24 Feb 2015
Print article
Image: UltraShape Ultrasound Machine (Photo courtesy of Syneron Medical).
Image: UltraShape Ultrasound Machine (Photo courtesy of Syneron Medical).
A leading producer of aesthetic medical devices has developed the first noninvasive body contouring treatment approved by the United States Food and Drug Administration (FDA). Most women are unhappy about their abdominal area, and the new treatment offers a safe and efficient treatment for reducing abdominal fat by an average of 3.3–6.35 cm.

The treatment makes use of pulsed focused ultrasound to precisely target subcutaneous fat, without heating it, while keeping blood vessels, nerves, muscles and other surrounding tissue intact. The treatment does not require any surgery, anesthetics, or recovery time, and targets fat deposits that are difficult to remove with diet, and exercise alone.

The treatment was developed by Syneron Medical (Irvine, CA, USA) and is called UltraShape. The treatment destroys fat cells by emitting acoustic waves of ultrasonic energy, and focusing them into a confined focal volume. UltraShape transmits pulsed ultrasound, which restricts temperature elevation to less than 0.5 °C increase. The treatment targets only subcutaneous fat at a known depth, and destroys fat instantly, and selectively.

Shimon Eckhouse, PhD, Chairman of the Board of Directors for Syneron Candela, stated, "UltraShape uses ultrasound technology that was perfected in 10 years of research and development by world leading scientists and doctors to noninvasively destruct fat without any damage to surrounding tissue. UltraShape efficiency in noninvasive fat destruction has been studied and proven in more than 13 clinical studies with more than 900 patients treated by this technology. These studies have also demonstrated the excellent safety record of the technology as well as its ability to do it with no downtime to the patient."

Related Links:

Syneron Medical
Ultrashape 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Hydrogen Peroxide Sterilizer
HMA-30

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.